Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children
JS Hyams, A Griffiths, J Markowitz, RN Baldassano… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: The IMAgINE 1 study (NCT00409682) evaluated the safety and
efficacy of adalimumab double-blind maintenance dosing regimens following open-label …
efficacy of adalimumab double-blind maintenance dosing regimens following open-label …
[PDF][PDF] Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
RB COLLETTI, M DUBINSKY, J KIERKUS… - …, 2012 - naspghan.org
BACKGROUND & AIMS: The IMAgINE 1 study (NCT00409682) evaluated the safety and
efficacy of adalimumab double-blind maintenance dosing regimens following open-label …
efficacy of adalimumab double-blind maintenance dosing regimens following open-label …
Safety and efficacy of adalimumab for moderate to severe crohn's disease in children
JS Hyams, A Griffiths, J Markowitz… - …, 2012 - mayoclinic.elsevierpure.com
Background & Aims: The IMAgINE 1 study (NCT00409682) evaluated the safety and efficacy
of adalimumab double-blind maintenance dosing regimens following open-label induction …
of adalimumab double-blind maintenance dosing regimens following open-label induction …
[引用][C] Safety and efficacy of adalimumab for moderate to severe crohn's disease in children
JS Hyams, A Griffiths, J Markowitz, RN Baldassano… - Gastroenterology, 2012 - elibrary.ru
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children.
JS Hyams, A Griffiths… - … Bowel Disease Monitor, 2012 - search.ebscohost.com
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children Page
1 exist for clinicians who encounter the thiopurine side-effects that potentially mean …
1 exist for clinicians who encounter the thiopurine side-effects that potentially mean …
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children.
JS Hyams, A Griffiths, J Markowitz… - …, 2012 - europepmc.org
Methods We studied 192 patients with Pediatric Crohn's Disease Activity Index (PCDAI)
scores> 30 for whom conventional treatment was unsuccessful. Patients received open …
scores> 30 for whom conventional treatment was unsuccessful. Patients received open …
Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
JS Hyams, A Griffiths, J Markowitz, RN Baldassano… - Gastroenterology, 2012 - infona.pl
The IMAgINE 1 study (NCT00409682) evaluated the safety and efficacy of adalimumab
double-blind maintenance dosing regimens following open-label induction for pediatric …
double-blind maintenance dosing regimens following open-label induction for pediatric …
[PDF][PDF] Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
RB COLLETTI, M DUBINSKY, J KIERKUS… - …, 2012 - naspghan.org
BACKGROUND & AIMS: The IMAgINE 1 study (NCT00409682) evaluated the safety and
efficacy of adalimumab double-blind maintenance dosing regimens following open-label …
efficacy of adalimumab double-blind maintenance dosing regimens following open-label …
Safety and Efficacy of Adalimumab for Moderate to Severe Crohn's Disease in Children
JS Hyams, A Griffiths, J Markowitz… - …, 2012 - gastrojournal.org
Background & Aims The IMAgINE 1 study (NCT00409682) evaluated the safety and efficacy
of adalimumab double-blind maintenance dosing regimens following open-label induction …
of adalimumab double-blind maintenance dosing regimens following open-label induction …
Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children
JS Hyams, A Griffiths, J Markowitz… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Background & aims The IMAgINE 1 study (NCT00409682) evaluated the safety and efficacy
of adalimumab double-blind maintenance dosing regimens following open-label induction …
of adalimumab double-blind maintenance dosing regimens following open-label induction …